United States

People: Merck KGaA (MRCG.DE)

MRCG.DE on Xetra

23 Sep 2016
Change (% chg)

€0.06 (+0.06%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Reckmann, Bernd 

Dr. Bernd Reckmann is Member of the Executive Board, CEO Life Science and Performance Materials at Merck KGaA since March 2015. He is Member of the Executive Board, General Partner and Head of the Chemicals Business Sector at Merck KGaA since January 1, 2007. He studied Biochemistry at Gottfried Wilhelm Leibniz Universitaet Hannover, Germany, from 1976 to 1984, and completed his studies with a doctorate. He has worked in the Biochemistry Department at the University of Bayreuth from 1984 to 1986. Dr. Reckmann joined the diagnostics research unit of Merck in Darmstadt in 1986. From 1993 to 1998, he worked in Marketing and Sales within the laboratory and diagnostics business. He was appointed Head of the Life Science Products division in 1998. He became Head of Strategic Innovation at Merck in 2004 before being appointed president of the Merck companies in Korea. He is responsible for German region, including Human Resources, Site Management Darmstadt and Gernsheim, Asia, Chemicals division in the United States, Russia, Australia and New Zealand. He has been on the Board of Millipore Corp. in the United States and Millipore Corp. in Puerto Rico since July 2010.

Basic Compensation

Total Annual Compensation, EUR 4,777,000
Restricted Stock Awards, EUR 765,000
Long-Term Incentive Plans, EUR --
All Other, EUR --
Fiscal Year Total, EUR 5,542,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --